Janoshik Lab
Lab Result: Cagrilintide 10mg
(Batch CAG02)
Avg. purity
99.66%
Avg. mass:
10.28 mg
Result Date
July 16, 2025
Date added
July 23, 2025
Each vial contains 10mg of highly pure Cagrilintide.
Cagrilintide is a novel peptide developed as a treatment for obesity and weight management. It is a dual agonist that targets both the GLP-1 (glucagon-like peptide-1) and the amylin receptor, which helps to regulate appetite and glucose metabolism. By enhancing feelings of fullness and reducing hunger, cagrilintide aims to aid in weight loss and improve metabolic health.
Add 1mL of bacteriostatic water to get a solution that is 10mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 1mg of Cagrilintide.
This product must be refrigerated after reconstitution.